Navigation Links
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Date:8/14/2009

Tel: +1-626-456-2789 Email: elaine@biostarpharmaceuticals.com John Mattio HC International, Inc. Tel: +1-914-669-5340 Email: john.mattio@hcinternational.net Web: http://www.hcinternational.net - FINANCIAL TABLES FOLLOW - BIOSTAR PHARMACEUTICALS, INC. CONSOLIDATED BALANCE SHEETS June 30, December 31, 2009 2008 (Unaudited) ASSETS Current Assets Cash and cash equivalents $1,946,696 $758,316 Accounts receivable 15,298,959 11,700,841 Inventories 560,522 315,745 Prepaid expenses and other receivables 5,735,741 2,926,505 Total Current Assets 23,541,918 15,701,407 Property and equipment, net 5,513,242 5,930,467 Intangible assets, net 7,202,230 7,365,765 Total Assets $36,257,390 $28,997,639 Current Liabilities Accounts payable and accrued expenses $2,305,913 $2,191,976 Customer and other deposits 2,705,470 2,592,250 Value-added tax payable 918,241 527,103 Income tax payable 1,359,276 413,205 Total Current Liabilities 7,288,900 5,724,534 Commitment Stockholders'
'/>"/>
SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
3. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
4. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
5. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
9. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
10. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... RBJ today announces the firm brokered a long-term lease totaling ... biopharmaceutical company, at Two Ledgemont Center in Lexington, ... president, and Brian Cohen , senior vice president, represented ... 95 Hayden Ave. Photo - http://photos.prnewswire.com/prnh/20150122/170765 ...
(Date:1/22/2015)... Pipette.com has added the Eppendorf ... portfolio of Eppendorf products. , The Eppendorf Centrifuge 5424/5424 ... 5424/5424 R and receive the following:, , ... or Eppendorf Reference 2 ,     3 Free ...
(Date:1/22/2015)... Denville, NJ (PRWEB) January 22, 2015 ... shearing technologies such as the Bioruptor® and complete ... semi-automation system for chromatin immunoprecipitation, alleviating the need ... reagents and controls needed for ChIP of histones ...
(Date:1/22/2015)... 22, 2015  Derma Sciences, Inc. (Nasdaq: ... advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, ... added to the Premier, Inc. Regenerative Skin Grafting ... the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue ...
Breaking Biology Technology:Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... , , SAN DIEGO, ... announced today that Kevin Gorman, President and Chief Executive Officer of ... Conference in New York. , , The ... Eastern Time (ET)/10:00 a.m. Pacific Time (PT). The presentation will ...
... , SAN JOSE, Calif., Sept. 16 ... with more than 1,100 physicians, in Milwaukee, WI, has selected the ... report adverse and near-miss events, as well as to manage the ... (CM) modules, part of the SRM solution, were chosen from among ...
... , KNOXVILLE, Tenn., Sept. 16 Marking a ... cancer, EDP Biotech Corporation (EDP), a ... that its ColoMarker(TM) assay achieved 100 percent detection rate for ... trials. ColoMarker is the first assay of its kind to ...
Cached Biology Technology:The Medical College of Wisconsin Adopts Quantros Event Manager(TM) and Claims Manager(TM) for Comprehensive Malpractice Litigation Management 2New Assay Detects 100 Percent of Stage I, II and III Colon Cancers in Pre-Clinical Trials 2New Assay Detects 100 Percent of Stage I, II and III Colon Cancers in Pre-Clinical Trials 3
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a leader ... announced the launch of a TR-FRET (time resolved ... Transcreener UDP Assay, a high throughput screening assay ... assay will allow for sensitive detection of hundreds ...
(Date:1/22/2015)... Report Issued by Small Cap IR. In 2011, Nilson Report,s ... at merchants on the leading payment cards rose to $135.3 ... and prepaid cards reached 6.54 billion.  Eight million credit card ... in 2012, and credit and debit card fraud resulted in ...
(Date:1/22/2015)... CHARLOTTE, N.C. , Jan. 22, 2015 Infinisource has ... introduction of the G2 model. The G2 sets a higher ... company,s iSolved human capital management solution. With plug-and-play installation, touch ... G2 time clock provides a robust time collection solution for ...
Breaking Biology News(10 mins):BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Infinisource's NXG series sets new time clock standard 2
... who understand the geological age of the Earth (4.5 billion ... evolution, according to a University of Minnesota study published in ... The finding could give educators a new strategy for teaching ... rather than biological science classes. Researchers Sehoya Cotner and ...
... and arrhythmias (irregular heartbeat) have limited effectiveness and have ... of Iowa study suggest a way that treatments could ... target only key heart-related mechanisms. The team, which ... it might be possible to use drugs that maintain ...
... gained new insight into why a relatively short-term hearing deprivation ... hearing is restored to normal. The research, published by Cell ... Neuron , reveals that, much like the visual cortex, development ... not receive appropriate stimulation at just the right time. ...
Cached Biology News:Students' perceptions of Earth's age influence acceptance of human evolution, says U of Minn. study 2Research points to way to improve heart treatment 2Research reveals that temporary hearing deprivation can lead to 'lazy ear' 2
... Vector NTI Suite for Mac OS ... environment for DNA and protein sequence analysis ... Mac OS X (Table 1). With Vector ... analyze transform share and publicize diverse types ...
...
... Inhibits several important steps of angiogenesis including proliferation, ... Also reduces intracellular reactive oxygen species (ROS) level, ... cells. Formula: ... MolWeight: 360.31484 ...
... includes the pZErO-1 vector with Zeocin resistance ... vector utilizes positive selection to eliminate high ... resistance gene reduces the overall vector size ... kit contains all of the reagents you ...
Biology Products: